(Q31729142)

3 July 2017

1 reference

title

Statins in children: what do we know and what do we need to do? (English)

1 reference

3 July 2017

Black DM

1

1 reference

3 July 2017

publication date

1 January 2001

1 reference

Current Atherosclerosis Reports

3 July 2017

published in

1 reference

3 July 2017

volume

3

1 reference

3 July 2017

issue

1

1 reference

3 July 2017

page(s)

29-34

1 reference

Association of specific LDL receptor gene mutations with differential plasma lipoprotein response to simvastatin in young French Canadians with heterozygous familial hypercholesterolemia.

3 July 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11883-001-0007-X

Effects of pravastatin and cholestyramine on gonadal and adrenal steroid production in familial hypercholesterolaemia

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11883-001-0007-X

Security and maximal tolerated doses of fluvastatin in pediatric cancer patients

21 January 2018

1 reference

12 December 2020

Diet only and diet plus simvastatin in the treatment of heterozygous familial hypercholesterolemia in childhood

1 reference

12 December 2020

Treatment of familial hypercholesterolemia with drugs in children

1 reference

12 December 2020

An overview of the clinical safety profile of atorvastatin (lipitor), a new HMG-CoA reductase inhibitor

1 reference

12 December 2020

Abnormal growth hormone secretory dynamics in children with familial hypercholesterolemia

1 reference

12 December 2020

Simvastatin use in children

1 reference

12 December 2020

Pharmacologic and surgical treatment of dyslipidemic children and adolescents

1 reference

12 December 2020

Safety and efficacy of treatment of pediatric cholesteryl ester storage disease with lovastatin

1 reference

12 December 2020

The association of LDL receptor activity, LDL cholesterol level, and clinical course in homozygous familial hypercholesterolemia

1 reference

12 December 2020

Hyperlipidaemia, diet and simvastatin therapy in steroid-resistant nephrotic syndrome of childhood

1 reference

12 December 2020

Response to drugs and diet in a compound heterozygote for familial hypercholesterolaemia

1 reference

12 December 2020

Decreased production of low density lipoprotein by atorvastatin after apheresis in homozygous familial hypercholesterolemia

1 reference

12 December 2020

American Academy of Pediatrics. National Cholesterol Education Program: Report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents

1 reference

12 December 2020

Atherogenesis in children: implications for the prevention of atherosclerosis

1 reference

12 December 2020

Long-term follow-up of children with familial hypercholesterolaemia treated with cholestyramine

1 reference

12 December 2020

Neonatal diagnosis of familial type-II hyperlipoproteinaemia

1 reference

12 December 2020

Long-term safety and efficacy profile of simvastatin

1 reference

12 December 2020

Pediatric familial type II hyperlipoproteinemia: therapy with diet and colestipol resin

1 reference

12 December 2020

Short-term efficacy and safety of pravastatin in 72 children with familial hypercholesterolemia.

1 reference

12 December 2020

Inhibition of cholesterol synthesis by atorvastatin in homozygous familial hypercholesterolaemia

1 reference

12 December 2020

Prenatal diagnosis of homozygous familial hypercholesterolaemia. Expression of a genetic receptor disease in utero

1 reference

12 December 2020

Efficacy of vitamin E compared with either simvastatin or atorvastatin in preventing the progression of atherosclerosis in homozygous familial hypercholesterolemia

1 reference

12 December 2020

Management of hyperlipidemia in children with refractory nephrotic syndrome: the effect of statin therapy

1 reference

12 December 2020

Expanded-dose simvastatin is effective in homozygous familial hypercholesterolaemia

1 reference

12 December 2020

Treatment of hypercholesterolaemia in children

1 reference

12 December 2020

Lovastatin therapy in receptor-negative homozygous familial hypercholesterolemia: Lack of effect on low-density lipoprotein concentrations or turnover

1 reference

12 December 2020

Treatment of familial hypercholesterolemia in children and adolescents: effect of lovastatin. Canadian Lovastatin in Children Study Group

1 reference

12 December 2020

Treating to meet NCEP-recommended LDL cholesterol concentrations with atorvastatin, fluvastatin, lovastatin, or simvastatin in patients with risk factors for coronary heart disease

1 reference

12 December 2020

Effects of combination therapy consisting of moderate-dose intravenous immunoglobulin G, pulsed methylprednisolone and pravastatin in children with steroid-resistant nephrosis

1 reference

12 December 2020

Safety profile of fluvastatin.

1 reference

12 December 2020

Familial combined hyperlipidemia in children: clinical expression, metabolic defects, and management

1 reference

12 December 2020

Lovastatin therapy for cholesterol ester storage disease in two sisters

1 reference

12 December 2020

Alagille syndrome today

1 reference

12 December 2020

Sitosterolemia: opposing effects of cholestyramine and lovastatin on plasma sterol levels in a homozygous girl and her heterozygous father

1 reference

12 December 2020

Efficacy and safety of lovastatin in adolescent males with heterozygous familial hypercholesterolemia: a randomized controlled trial

1 reference

12 December 2020

Clinical experience with lovastatin

1 reference

12 December 2020

Use of cholestyramine in treatment of children with familial hypercholesterolaemia

1 reference

12 December 2020

10.1007/S11883-001-0007-X

Identifiers

DOI

1 reference

Dimensions Publication ID

3 July 2017

1016244006

0 references

1 reference